Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS Gains 9%; BSE HEALTHCARE Index Up 0.7%
Wed, 3 Jul 13:11

KRSNAA DIAGNOSTICS Gains 9%; BSE HEALTHCARE Index Up 0.7%Image source: DNY59/www.istockphoto.com

KRSNAA DIAGNOSTICS share price has zoomed 9% and is presently trading at Rs 685.0.

Meanwhile, the BSE HEALTHCARE index is at 37,432.2 (up 0.7%).

Among the top gainers in the BSE HEALTHCARE index today are FDC (up 6.5%) and IPCA Labs (up 3.4%).

AARTI DRUGS (down 1.7%) and CAPLIN POINT (down 1.5%) are among the top losers today.

Over the last one year, KRSNAA DIAGNOSTICS has moved up from Rs 584.5 to Rs 685.0, registering a gain of Rs 100.5 (up 17.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 37,432.2, registering a gain of 46.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 92.9%), Cadila Healthcare (up 88.4%) and GSK Pharma (up 85.0%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,967.7 (up 0.7%).

The top gainers among the BSE Sensex today are HDFC Bank (up 2.6%) and Axis Bank (up 2.3%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,281.8 (up 0.7%). Tata Consumer Products and HDFC Bank are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 79,967.7, registering a gain of 14,762.7 points (up 22.6%).

KRSNAA DIAGNOSTICS Financial Update...

KRSNAA DIAGNOSTICS net profit fell 1.0% YoY to Rs 187 million for the quarter ended March 2024, compared to a profit of Rs 189 million a year ago. Net sales rose 24.8% to Rs 1,663 million during the period as against Rs 1,332 million in January-March 2023.

For the year ended March 2023, KRSNAA DIAGNOSTICS reported 9.2% decrease in net profit to Rs 621 million compared to net profit of Rs 684 million during FY22. Revenue of the company grew 7.0% to Rs 4,871 million during FY23.

The current Price to earnings ratio of KRSNAA DIAGNOSTICS, based on rolling 12 month earnings, stands at 38.9.


Equitymaster requests your view! Post a comment on "KRSNAA DIAGNOSTICS Gains 9%; BSE HEALTHCARE Index Up 0.7%". Click here!